Cite
HARVARD Citation
Tran, P. et al. (2023). Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. Journal of clinical oncology. 41 (6), pp. 1307-1317. [Online].